Don't wanna be here? Send us removal request.
Text
Breast Pump Market Increasing Awareness About Breastfeeding are Major Factor Driving the Growth of USD 1.74 billion by 2025
Apr 01, 2021: Global Breast Pump Market size is expected to reach USD 1.74 billion by 2025. Breast pump is generally used by working women to continue breastfeeding their babies while still at work. Also, breast pump is used by those mothers to stimulate lactation in case of low milk supply and when the baby is unable to suck milk due to some physical condition. Lactating mothers are becoming increasingly aware about the importance & benefits of breastfeeding. The breast pump market is expected to register a CAGR of 7.8% in the upcoming period as the scope, product types, and its applications are increasing across the globe.
Many parents use them to continue breastfeeding after they return to work. They express their milk at work, which is later bottle-fed to their child by a caregiver. This use of breast milk is widespread, where paid family leave is one of the shortest in the developed world. Many parents use them to continue breastfeeding after they return to work. They express their milk at work, which is later bottle-fed to their child by a caregiver. This use of breast milk is widespread in the United States, where paid family leave is one of the shortest in the developed world. A breast pump may be also used to address a range of challenges parents may encounter breast feeding, including difficulties latching, separation from an infant in intensive care, to feed an infant who cannot extract sufficient milk itself from the breast, to avoid passing medication through breast milk to the baby, or to relieve engorgement, a painful condition whereby the breasts are overfull.
Download Sample Copy Of This Report At: https://www.millioninsights.com/industry-reports/breast-pump-market/request-sample
The increasing employment rate and favorable demographics are the main factors driving the market growth in the years to come. Additionally, governments’ initiatives such as the BFSI (Baby Friendly Hospital Initiative) are expected to drive the industry growth in the next couple of years. In the market, various types of breast pumps are available such as manual, electric breast pumps, and battery-powered. Electric breast pumps are identified as the most lucrative segment in the market and expected to hold the largest market share during the forecast period due to their greater efficiency in terms of comfort and user-friendliness.
Applications such as personal use and hospital grade could be explored in breast pump industry. The “hospital grade” devices are expected to hold the highest market share in the years to come due to the presence of large number of hospitals and increasing global birth rate. Electric breast pumps for “personal use” are expected to grow at a high CAGR in the upcoming period due to growing number of working mothers and rising healthcare expenditure.
Read Complete Report with TOC @ https://www.millioninsights.com/industry-reports/breast-pump-market
The factors that play an important role in the growth of breast pump market include increasing demand, growing population, increasing urbanization & industrialization, growing working women, changing lifestyle, increasing patient disposable income, rising awareness about the breast pump, technological advancements such as introduction of hands-free breast pumps, favorable change in reimbursement policies, rising birth rates in emerging countries, and growing healthcare industry. Moreover, increasing healthcare expenditure and improving healthcare infrastructure in developing economies are anticipated to boost the market growth in the upcoming period. However, high cost of breast pumps along with low awareness, risk & side effects related to breast pumps are negatively impacting the growth of breast pump industry.
The market is widely analyzed based on different regional factors such as gross domestic product (GDP), demographics, acceptance, inflation rate and others. The market is categorized based on product, technology, application and geography. The market is classified into product such as closed system and open system. The “closed system” segment dominated the overall market share in terms of revenue in 2016 due to their higher prices and increasing usage rates. This segment is expected to hold the large market share in the next couple of years because it offers a more hygienic milk collection mechanism.
The key players contributing to the robust development of the breast pump industry include Medela Inc., Philips Avent, Bailey Medical Engineering, Ameda Breastfeeding Solutions, Chicco, Hygeia Medical Group, MAM, Evenflo Feeding, Pigeon Corporation, Mayborn, Whittlestone, Spectra Baby, Albert Manufacturing USA, Linco Baby Merchandise Works Co., Whittlestone Inc. and Lansinoh Laboratories. These market players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Brain Implants Market is Expected to Expand at a Compound Annual Growth Rate USD 8.29 billion by 2025
Apr 01, 2021: Industry Insights
Global Brain Implants Market size is expected to reach USD 8.29 billion by 2025 as the scope and its applications are rising enormously across the globe. Brain implants is also termed as neural implants, are mechanical systems that are usually used to invigorate structures and parts of the nervous system with the help of the record the electrical activity of nerve cells or implanted electrical circuitry. These devices are attached to the brain cortex or placed on the surface of the brain. Brain Implants Market size is expected to grow at a CAGR of 11.9%.
Brain implants, often referred to as neural implants, are technological devices that connect directly to a biological subject's brain – usually placed on the surface of the brain, or attached to the brain's cortex. A common purpose of modern brain implants and the focus of much current research is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. This includes sensory substitution, e.g., in vision. Other brain implants are used in animal experiments simply to record brain activity for scientific reasons.
Download Sample Copy Of This Report At: https://www.millioninsights.com/industry-reports/brain-implants-market/request-sample
Rising use of enhanced technology in brain implants, growing occurrence of Parkinson’s disease, high demand for brain implants, growing disposable income in established countries are documented as major factors of Brain Implants Market size that are estimated to enhance the growth in the years to come. However, high cost of brain implants and presence of alternative enhanced technological inventions are the factors that may restrain overall market growth in the years to come.
This mechanical system enhances memory, senses, and physical movement and communicates with the nervous system. Neural implants have been used to support people recover abilities that have been vanished. It includes generating interfaces between neural systems and computer chips, generally named brain-machine interfaces. A mutual drive of modern brain implants and the emphasis of current research is founding a biomedical prosthesis evading areas in the brain that became dysfunctional after head injuries or stroke. This comprises sensory replacement, e.g. in vision.
Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/brain-implants-market
Brain Implants Market size is segmented based on product types, applications, and region. Vagus nerve stimulator (VNS), deep brain stimulator (DBS), and spinal cord stimulator (SCS) are the product types that could be explored in Brain Implants in the forecast period. In 2016, deep brain stimulator sector accounted for the largest market share of 37.0% in terms of revenue and is estimated to lead the overall market in the coming years. This may be because of rising use in numerous applications and growing occurrence of Parkinson’s disease. Moreover, it is exclusively used to treat numerous neurological disorders like Alzheimer’s disease, obsessive-compulsive disorder (OCD), epilepsy, dystonia, and essential tremor. Also, Vagus nerve stimulator is estimated to grow at fastest pace in the coming years, as rising occurrence of epilepsy.
The market may be categorized based on applications like Alzheimer’s disease, chronic pain, essential tremor, epilepsy, depression, Parkinson’s disease, and others. Chronic pain segment accounted for the largest market share in 2016 and is estimated to continue its dominance in the coming years. This may be because of, rising chronic pain due to circumstances like neuropathy, lumbar and radiculitis, complex regional pain syndrome, and failed back surgery and high demand for stimulators used during chronic back and neck pain. According to Pain Doctor Report, in 2017, 14000 patients used spinal cord implants. However, Parkinson’s disease sector is estimated to grow at highest CAGR in the coming years. This may be because of rising occurrence of disease and reduction in coffee consumption and smoking rate.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Disposable Medical Sensors Market is Expected to Open New Opportunities in the Industry Thus Boosting the Growth of USD 12.3 billion in 2025
Mar 31, 2021: Industry Insights
The disposable medical sensors market size was valued at USD 5.1 billion in 2016 and it is anticipated to report USD 12.3 billion in 2025, with a growth rate of 10.2% CAGR. The primary reason for the sector to witness significant growth is due to the rising end-user demand from medical and pharmaceutical industries. Rising prevalence of infectious diseases, growing government initiatives towards innovating medical sensor products, and increasing awareness among people regarding benefits are the key drivers expected to propel the market growth over the forecast period. Few other factors such as growing adoption in the companies as a faster medical analysis technique, rising awareness regarding product low cost, and increasing need to restrict escalating healthcare related costs are anticipated to fuel the disposable medical sensors industry demand over the next seven years. However, rising need of clinical data requirement for the product development, and growing insufficient reimbursement policies for sensor devices are few factors projected to challenge the market and thus hindering its growth over the forecast period.
Download Sample Copy Of This Report At: https://www.millioninsights.com/industry-reports/disposable-medical-sensors-market/request-sample
The industry segmentation on the basis of technology includes pressure sensors, image sensors, accelerometers, biosensors and temperature sensors. Rising demand for constant diagnostic and monitoring devices including blood glucose monitors and cardiac pacemakers are the few dynamics likely to propel the biosensor segment market over the next seven years. The biosensors segment is thus anticipated to account for major market share by 2020.
On a contrary, rising need for sensors in domestic as well as in clinics applications for the treatment and diagnostic purposes are projected to drive the market growth over the next seven years. Increasing R&D endeavours with technological advancements has enabled the disposable medical sensor industry to witness advanced products including MEM sensor technology for detecting C - reactive protein, fibre optic technology, and cancer tracking sensors, which are anticipated to propel the market demand over the forecast period. Furthermore, the growing prevalence of long term and chronic diseases coupled with rising demand for patient diagnosis and monitoring has enabled the market to expect significant growth by 2020. The increasing adoption of strip and wearable medical sensors that help in continuous patient diagnosis is expected to open new opportunities in the industry, thus boosting the growth by 2020.
Click For Report Details @ https://www.millioninsights.com/industry-reports/disposable-medical-sensors-market
Product Insights
The disposable medical sensors industry is majorly segmented by product into temperature sensors, biosensors, accelerometers, pressure sensors, and image sensors. Image sensor segment is projected to witness the fastest growth of more than 22% CAGR over the forecast period owing to rising awareness and acceptance of CMOS image sensors. On the other hand, biosensors are anticipated to account for the largest market share of more than 65% over the next seven years primarily due to the growing usage of endoscopy products such as camera pills and increasing need of endoscopic procedures for numerous medical operations.
The market is also bifurcated by placement of sensors into strip sensors, implantable sensors, invasive sensors, ingestible sensors, and wearable sensors. Strip sensors are anticipated to account for a major market share of more than 45% over the next seven years and thus reaching USD 2.94 billion by revenue in 2020. Strip sensor market is expected to witness a growth rate of more than 10% over the next seven years owing to rising diagnostic applications globally and growing awareness regarding disposable medical sensors cost effectiveness. In addition, increasing penetration of domestic healthcare medical sensor products coupled with home care glucose monitoring is also projected to fuel the sector growth over the next seven years.
Application Insights
The disposable medical sensor market is segmented by application into diagnostic testing devices, patient monitoring devices, therapeutic devices and imaging devices. In 2013, diagnostic testing devices application segment accounted for major market share and owing to rising prevalence of chronic disease coupled with increasing geriatric population base the segment is anticipated to witness similar trend by 2020. On the other hand, patient monitoring devices segment is projected to report the fastest growth over the forecast period majorly due to growing number of patients suffering from diabetes and cancer. The aforementioned factors are attributed to expect significant sector growth over the next seven years.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Women’s Health Market is Expected to Emerge as a Major Revenue Generator USD 51.3 billion by 2025
Mar 25, 2021: The global women’s health market size was valued at USD 36.5 billion in 2016 and is expected to reach USD 51.3 billion by 2025, with a CAGR of 3.9%. Being a man or a woman has an important impact on health; as a result of both biological and gender-related differences. The health of women and girls is of particular concern because in many societies they are disadvantaged by judgment rooted in sociocultural factors. The general practice management of women’s health involves a general patient-centered approach toward the physical, mental, and emotional health of women, their families, and their relationships. Women’s health needs to be understood in the perspective of their psychological and cultural environment.
Women’s Health Market is segmented on the basis of application and analysis, drug class, and region. Segmentation by application and analysis of women’s health market covers Postmenopausal osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, Polycystic ovary syndrome (PCOS). Endometriosis is a problem affecting a woman’s uterus; the place where a baby grows when a woman is pregnant. The misplaced tissue can cause pain, infertility, and very heavy periods. Polycystic ovary syndrome happens when a woman’s ovaries or adrenal glands produce more male hormones than normal.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/womens-health-market/request-sample
In 1900, a woman’s lifespan was about 50 years but now in the new millennium, average life expectancy for American women is 82 years of age, and it is continuing to rise. Gynecology is the primary branch of medical science concerned with women’s health issues. The National Institutes of Health (NIH) established Women’s Health Initiative (WHI) in 1991 to address the most common causes of death, disability, and impaired quality of life in postmenopausal women. The Agency of Healthcare Research and Quality (AHRQ) supports research on all aspects of healthcare provided to women.
Market size by drug class includes Evista, Xgeva, Mirena, Zometa, Minastrin 24FE, Nuvaring, Forteo, Premarin, Actonel, Ortho-Tri-Cy LO 28, and Reclast. On the basis of geography, women’s health therapeutics market size comprises four major regions: North America, Europe, Asia Pacific, and Rest of the World. North America and Europe are the foremost markets for women health therapeutics. This is because of increased awareness regarding women health. Contraception and fertility control are supported by the governments of developing countries such as India and China to curb the growing population. This trend is expected to show positive growth of women’s health market from 2014 to 2025.
Click Here For Complete Report @ https://www.millioninsights.com/industry-reports/womens-health-market
With many countries pitching for improving the healthcare facilities for women, the market for women’s health will have a positive viewpoint in the years to come. As a part of social security measure many countries have considerably increased their healthcare budgets. The U.S. government spent 17% of their GDP on the healthcare sector in 2014.
Women with PCOS are at higher risk of developing diabetes and heart disease. Women who can get pregnant but unable to stay pregnant is also considered as infertile. About 10% (6.1 million) of women in United States aged 15-44 years have difficulty getting pregnant or staying pregnant. A woman has reached menopause when she has not had a period for 12 months in a row (45-55 age). Menopause happens because the woman’s ovary stops producing the hormones estrogen and progesterone.
Contraception is a method of birth control available to prevent unintended pregnancy. Osteoporosis is of major concern among post-menopausal women and this disease is projected to affect around 20 percent of post-menopausal women. The disease is characterized by substantial loss of bone mass and increasing the risk of serious fractures. Currently the menopause therapeutics market is determined by hormone therapeutics. In 2015, the postmenopausal osteoporosis segment conquered the market and accounted for more than 37% of the market share.
The key players of women’s health market are Allergan, Bayer Healthcare, Merck, Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, Ferring International Center.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Atherectomy Devices Market Witnessed High-Income Countries Witnessed a Growth of USD 894.69 million by 2025
Mar 24, 2021: The global atherectomy devices market size was valued at USD 488.04 million in 2016 and is anticipated to reach USD 894.69 million by 2025, with CAGR of 6.97% over the forecast period. Increase in prevalence of Peripheral artery disease (PAD) and Deep vein thrombosis (DVT) is expected to drive the market growth over the forecast period. Increase in aging population in the US and in economically developed countries resulting in high requirement of medical devices for chronic illness. This is expected to escalate the market growth of Atherectomy devices. Major factors such as rising life expectancy declining fertility rates play a major role in market growth in the foreseeable future.
Change in lifestyle trends and eating habits increase Consumption of cholesterol and fatty foods among individuals and lack of exercise which has been a major reason for coronary artery disease and high risk of heart attacks. Depending on the severity of the health issue atherectomy devices are used in the surgery by the doctors. Diabetes, high blood pressure, obesity and smoking causes the blood arteries to marrow and limit the blood supply to the heart. It is estimated that 382 billion people throughout the world have diabetes. Environmental factors such as foods, viruses, toxins and unbalanced work life play a role in development of diabetes. Growing number of patients with these vascular diseases are expected to proliferate the demand for atherectomy devices.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/atherectomy-devices-market-size/request-sample
Adopting advanced technology by using laser, ultraviolet radiation and recombinant issue technology and 3D image generation provides a better scope for the market. Added benefits such as minimal incisions, higher surgical restoration rate, low postoperative complications increase more patients opting for atherectomy devices. New technological advancements and the recent FDA approval of Two drug coated balloons are increasing atherectomy procedural volume and driving growth in the demand for atherectomy devices.
Recalls of medical devices has been a major issue in pharmaceutical industry. Every device should maintain the standard quality and safety measures set by the Food and Drug Administration (FDA). All the manufacturing firms should ensure that the products are safe and do not endanger the end consumer.
Athrectomy devices face a tough competition from Catheter (Tornus) which has been developed for chronic total occlusion recanalization. However, Catheter has a lower success rate of only 77% as compared to the traditional atherectomy devices with 95%. Tornus catheter is also associated with longer procedural duration time with 144 minutes versus the atherectomy devices 115 minutes.
Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/atherectomy-devices-market-size
Lack of product differentiation forms a major challenge in the atherectomy market. Most companies trying to enter the market find it hard to overcome the product differentiation because they require high investment and lack resources to create products that can compete with the existing ones. High cost and limited awareness in certain regions of the world act as a restraint for the market growth.
Atherectomy technique is a popular substitute for stents and angioplasty treatments. In stents and angioplasty, the deposited plaque is pushed inside the blood vessel, however in atherectomy the plaque is removed by using surgical methods. The technique has advantages over the other methods by providing increased wound healing rate
The market has been classified on the basis of its device functions such as rotational, orbital, excimer laser, excisional, directional and Jetstream atherectomy. The largest share of the market is occupied by orbital and directional atherectomy due to minimal invasive treatment, blood flow restoration, reduction in procedure time and application in more complex cases. Market players are coming with better techniques and products to meet the requirement of the consumers.
The market is segmented on the basis of geography such as North America, Europe, Asia pacific. North America is the leading player in the market followed by Europe. Peripheral artery disease affects nearly 10 million people and around 720,000 die every year due to heart attack in US making it the potential market for the devices. Higher number of surgeries are being performed in US and Europe due to better awareness among people and also availability of resources making them the leading regions in the market.
Asia pacific can be a potential market for atherectomy devices since countries such as India and china possess the largest number of cardiac patients with an annual incidence of 7 million strokes. Tobacco consumption is rapidly increasing in south Asian countries in conjunction with economic expansion increasing their risk of artery diseases.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Anesthesia CO2 Absorbent Market Increasing Incidences of Chronic Conditions are Expected to Increase Demand USD 79.1 million by 2022
Mar 24, 2021: The global Anesthesia CO2 Absorbent Market size was valued at USD 43.7 million in 2015 and is expected to reach USD 79.1 million by 2022. Global anesthesia CO2 Absorbent demand is expected to grow at a high rate on account of its increasing application in medical science. The major factors contributing to the market growth is increasing incidence of accidents, chronic diseases, the ageing population and a high number of surgeries. Rising occurrences of chronic health diseases are expected to contribute to increasing demand for surgeries. This in turn is expected to contribute to growing volume of anesthesia, therefore propelling the overall market growth. Further, safety parameters and guidelines imposed the governing institutes help in driving the demand. These institutes include the CEA, CDC and Anesthesia Patient Safety Foundation.
Trends have shown that there have been an increasing number of people suffering from diseases which include neurological conditions, respiratory disorders, cardiac arrest and diabetes. These kind of incidences has resulted in surgical requirements which in turn has propelled the industry growth. As per the world health organization, approximately 8 % of the global population has been suffering from respiratory disorders. Aging population and geriatric populations has significantly contributed in driving the overall industry growth.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/anesthesia-co2-absorbent-market/request-sample
Healthcare sector largely depends on government policies and initiatives. Government regulatory bodies help in establishing best practices for modern healthcare facilities. Medical institutions and manufacturing companies depend on the government in terms of financial support and best practice methods. Recent trends have shown that regulatory bodies have been supporting the healthcare for anesthesia disposables. This has fueled the anesthesia CO2 absorbent industry. Hospitals expansion and investments in modern infrastructure have helped the medical institutions in establishing grass root level medical networks. The European Investment Bank announced a financial aid of USD 150.9 million towards the establishment of Midland Metropolitan Hospital in Great Britain. This healthcare center is anticipated to provide services to patients related to trauma and accident. It aims at establishing itself as the biggest emergency department in the UK.
Read Complete Report with TOC @ https://www.millioninsights.com/industry-reports/anesthesia-co2-absorbent-market
Segmentation is done on the basis of product used which includes Medisorb, Dragersorb, Amsorb, Litholyme and Soda Lime. The majority of the market share is being captured by Medisorb, Amsorb and Dragersorb. These products are widely used on account of their superior characteristic over the counterparts. Products including SpiraLith have been showing a steady penetration in the market in recent years. Similarly, this kind of newer formulations is expected to change the market scenario in the near future. Medisorb has been dominating the market and it is expected to continue its lead over the forecast period on account of its vast network and product goodwill. Around one-fourth of the market share is held by Medisorb. Amsorb follows the demand and has shown a tremendous increase in recent years. Amsorb plus, a product from the Amsorb segment has been manufactured to eliminate toxic products formation which includes carbon monoxide and compound A. This kind of initiative by the manufacturers offers great opportunities for the growth of Amsorb segment.
Manufacturers are continuously focusing on prevention of fatal compound formation and thereby enhancing the absorption rate during the surgical process. This is achieved through continuous evolution and new absorbent formulations. Heavy investments by the manufacturing organisations in the field of research and new product development are expected to propel the market growth in near future. The industry is segmented on the basis of geography as into North America (the U.S., Canada, and Mexico), APAC (China, Japan, and India), Europe (Germany, the U.K., and France), Middle East and Africa and Latin America. North America dominates the anesthesia CO2 absorbent industry with approximately one-third global share. The primary reason for the dominance is developed healthcare sector and supportive government initiatives. Countries including the U.S and Canada have observed increasing flow of patients on account of medical tourism. Patients from around the globe have been glowing in the U.S on account of superior medical treatment and advanced surgery techniques.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Cardiovascular Information System Market is Expected to Witness Persistently Increasing Demand of USD 1.2 billion by 2024
Mar 24, 2021: The global cardiovascular information system (CVIS) market was valued at USD 616.7 million in 2015 and is anticipated to reach USD 1.2 billion by 2024. Global Cardiovascular information system (CVIS) market is expected to grow in coming years owing to the increasing incidence rate of cardiovascular disorders thereby pushing the need for streamlining the cardiac care workflow systems. Factor such as growing need to integrate CVIS with CPACS and EMR and other cardiology modules is anticipated to fuel the product segment. A cardiovascular information system is a data-driven system in which research material and clinical information software along with scientific advancement data are stored. It is a patient driven informatics obtained from ECG and EKG, Haemodynamic system and echo machines coupled with inventory, business analytics, and billing mechanisms. With reducing reimbursements, healthcare providers are striving to have a cost curbing solutions such as CVIS. However, the greater emphasis on EHR implementation and initial high cost of CVIS implementation are expected to be growth impeding factor during the forecast period.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/cardiovascular-information-system-cvis-market/request-sample
The increasing need for ease to access data in numerous healthcare institutes for the fast and effective treatment of the patients in expected to stimulate the product demand over the next seven years. The amalgamation of reports, images, measurements and waveforms into the patient's record assists to create an information management and enterprise medical imaging solution in a proficient manner. An integrated cardiac EMR in one database offers a single point of access to the historical and current cardiac information and images, including ECG and haemodynamic data. Customizable reporting tools for the electrophysiology labs and cath, vascular and echo departments, ECG department and nuclear cardiology department make it possible for users to quickly document and analyze care practices. Workplace quality web access to report completion and procedures enables users to carry out a variety of clinical care tasks from isolated locations.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/cardiovascular-information-system-cvis-market
Cardiovascular information system aims to approve an advanced level of evidence-based proficient standards in cardiac recovery. The system is an integrated haemodynamic system which is data-driven patient informatics it is capable of storing all the information related to cardiovascular disease patient. For efficient recording and reporting patient information all the information is stored in CVIS. In addition, the business operations including business analytics and making bill which are conventionally managed by the separate computer system and can also be managed and stored by undertaking the system. Further, the product is also capable of providing dynamic reporting such as measurements, images, and informatics that are structured in a template design for reliable delivery and effectiveness of patient reports. With the implementation of CVIS cardiologists have observed a noteworthy reduction in report delivery time.
CVIS market is studied with respect to three different segments such as application, delivery mode, and component. CVIS industry by application is further segmented into echocardiography lab solutions, catheterization lab solutions, vascular lab solutions and ECG data management solutions. A component segment of CVIS market is studied with respect to hardware, services, and software. CVIS market by delivery mode is further classified into a web hosted, cloud-based and on premise market. CVIS acts as a single platform, single storage solution having single point entry to physicians, cardiologist administrators regardless of users location. Clinical benefits include accessibility of patient’s clinical history to the cardiologist prior to the procedures thereby nullifying the need of doctor leaving critical ill patient’s bedside. Business benefits of CVIS allow administrators to manage statistical reporting, inventory, billing and overall workflow in a live environment.
Higher occurrence rate of cardiovascular diseases coupled with technological advancements are helping North American market to be most mature during the forecast period. The European market is expected to follow North American market. Asia pacific CVIS market is expected to experience a lucrative growth on account of rapidly improvising healthcare infrastructure, untapped opportunity and increasing penetration. The major participants operating in the cardiovascular information system market include Philips Healthcare, GE Healthcare, Siemens, McKesson Corporation, Cerner Corporation, Fujifilm Medical Systems, Digisonics, Agfa Healthcare and Merge Healthcare.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
DNA Vaccines Market is Growing at a faster Pace with Substantial Growth Rates at 2025
Mar 23, 2021: DNA vaccines market represent a holistic view as a protection against infectious disease and may enhance human and animal welfare, minimize antibiotic usage and also curtail the proliferation of pathogens. Injectable and edible DNA vaccines exhibit a determined approach for rapid immunization against several diseases that are problematic to eliminate traditional vaccines and antibiotics. Other potential uses of DNA vaccines are inclusive of autoimmune disease, allergies, and treatment of cancer. On the basis of geographic segmentation, the global DNA vaccines market spans North America, Latin America, Asia-Pacific, Middle-East, and Africa.
Other potent uses of DNA vaccines include low cost, ease of production and enhanced quality on heat stability, identical production processes for different vaccines. A DNA vaccine comprises a bacterial plasmid that induces the immune system. When a patient is administered with the DNA vaccine, the mechanism in their cells make a viral or bacterial protein in which their immune system considers as alien to the body. DNA vaccines are different to conventional vaccines are made up of bacteria or viruses or a part of bacteria or virus such as protein.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/dna-vaccines-market/request-sample
Advantages in using the DNA vaccines can be summed as such vaccines need short time span, easy to transport and service, are very cheap to make, and there is no risk to those who are involved in making the vaccine. Disadvantages include initial attempts to create DNA vaccines are less significant on consumption by human body and most of the DNA vaccines are not open for human use yet. Therefore, considering the pros and cons coupled with market dynamics, the global market for DNA vaccines witnesses a higher CAGR growth during the forecast period.
The key driving factors responsible for the growth of DNA vaccines market include growing vulnerability of population to infectious disease and rising number of antibiotics resistant pathogens have generated the need for effective and low cost vaccination which would provide lasting immunity. On the basis of disease type, the global DNA vaccines market is segmented into human DNA vaccines and animal DNA vaccines. Human DNA vaccines market is further segmented into HIV infection, cancer and infectious diseases.
Browse Full Report With TOC @ https://www.millioninsights.com/industry-reports/dna-vaccines-market
On the basis of technology, the global DNA vaccines market is segmented into pDNA vaccines technology and pDNA delivery technology. pDNA vaccines technology is further sub-segmented into therapeutic technology and preventive technology. pDNA delivery technology is further sub-segmented into uncomplexed pDNA, liposomes, gold particles, electroporation, bacteriophages, bacterial ghosts, nanoparticles and viruses.
On the basis of application, the global DNA vaccines market is segmented into human diseases, and veterinary diseases. Human diseases are further sub-segmented into oncology, allergies and infectious diseases. Oncology is further sub-segmented into pancreatic cancer, breast cancer, ovarian cancer, small cell lung cancer and melanoma. Infectious disease is further segmented into CMV, HBV, HCV, HIV and Influenza.
Veterinary disease is further sub-segmented into canine melanoma, leishmaniosis, and Equine West NileVirus. The key players in the global DNA vaccines market spans Novartis Animal Health, Inovio Biomedical Corp, Merck & Co, Dendreon Corporation, Pfizer pharmaceuticals, GlaxoSmithKline, Advance Bioscience Laboratories Inc, Indian Immunologicals Ltd, Xenetic Biosciences Inc, QED Biosciences Inc, Astellas Pharma, Vical, Sanofi and Tekmira Pharmaceuticals.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Flu Protection Kits Market Distribution Channel, Players Competition Situation & Trends in 2025
Mar 19, 2021: Flu is an acronym for “influenza”. Influenza is an infectious disease that is caused by the influenza virus. A person suffering from flu experiences fever, running nose, sore throat, muscle pain, cough, fatigue and headache. Till date, the most dangerous categories of flu’s determined are swine flu and Ebola virus. These bacteria are said to result into fatal consequences for victim as well medical caregivers on detection of mishandling procedures. Flu protection kits thus come into picture to prevent any catastrophic events.
A flu protection kit generally involves gloves, goggles, full body suits, bandage sprays, antibacterial wipes, tissues, environmental friendly bags, sanitizers, sheets and duct tapes. Such equipment helps the medical caregivers to functional efficiently and helps the victim to recover from such virus. Though flu protection kits do not totally eliminate the spread of viruses, they can absolutely reduce the risk of infection to a significant level. With the growing population, flu strains are being discovered frequently and it is obvious that the flu protection kit efficiently fights against harmful bacteria & virus.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/flu-protection-kits-market/request-sample
The major driving factors for the global flu protection kit are increasing global population, discovery of new and unknown strains of viruses and enhanced healthcare infrastructure in developing markets. In addition, government initiatives to implement proper handling techniques for flu patients have added to the growth of this market. Prominent market players enjoy a significant global position in terms of providing medicine& vaccination in the remote and rural areas of developing countries.
However, lack of awareness in public and no sufficient and concrete policies by the government is considered as some of the major hindrance in the global flu protection market. Possibilities such as compromising on safety of patients by providing cost-effective and low-quality flu protection kit is another danger the market witnesses.
Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/flu-protection-kits-market
On the basis of geographic segmentation, the global flu protection kits market spans North America, Europe, Middle-East, Asia-Pacific and Africa. North America dominates the global flu protection kits market owing to growing awareness of treatments and enhanced healthcare systems. APAC regions are projected to be the growing markets due to dense population, large and faster growing economies that have started focusing on improving healthcare regulations and infrastructure. The key players in the global flu protection kit market include e-first aid Supplies, Evav8, Pandemic Protection, Life Secure, Bell cross Medical, 1-800 Prepare, Quake Kare and Birdflu Smart.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
PV Market is Expected to Expand at a Compound Annual Growth Rate of USD 10.27 billion by 2025
Mar 17, 2021: The global Pharmacovigilance (PV) Market size is estimated to reach USD 10.27 billion by 2025, registering at a 13.1% CAGR over the forecast period as the scope and its applications are rising enormously across the globe. Pharmacovigilance (PV) is also termed as drug safety, is a science and activities relating to the prevention, detection, understanding, and assessment of adverse effects or other drug-related issues.
The factors that are playing a major role in the growth of pharmacovigilance market are the rising occurrence of adverse drug reactions (ADR), enhancement in development of ADR database and information system, and the rising demand from the end-users. Pharmacovigilance (PV) industry is segmented based on the clinical trial phase, service provider, type of methods, end-user, and region.
Phase IV, phase III, phase II, phase I, and pre-clinical are the clinical trial phase that could be explored in pharmacovigilance (PV) market in the forecast period. The phase IV sector accounted for the substantial market share of pharmacovigilance and is estimated to lead the overall market in the years to come.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/pharmacovigilance-pv-market/request-sample
Also, phase III sector is estimated to show lucrative growth in the years to come. Contract outsourcing, in-house, and other service providers could be explored in pharmacovigilance industry in the forecast period. Contract outsourcing sector accounted for the substantial market share of pharmacovigilance and is estimated to lead the overall market in the years to come.
Based on the type of method, HER mining, spontaneous reporting, cohort event monitoring, intensified ADR reporting, targeted spontaneous reporting, and others could classify pharmacovigilance market in the forecast period. Spontaneous report sector accounted for the significant market share of pharmacovigilance and is estimated to continue its dominance in the years to come. Also, the cohort event monitoring sector is estimated to grow at the fastest pace in the years to come.
The market may be categorized based on end-users like industrial, hospitals, research organizations, and others that could be explored in the forecast period. The hospitals sector accounted for the substantial market share of pharmacovigilance and is estimated to lead the overall market in the years to come. Also, the research organization sector is estimated to grow at the fastest pace in the years to come.
Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/pharmacovigilance-pv-market
Globally, North America accounted for the substantial share of pharmacovigilance industry and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the presence of key manufacturers in the region and the high investment in the development of new drugs. The United States and Canada are the major consumers of pharmacovigilance in the years to come.
Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period. The developing countries like India and China are the major consumers of pharmacovigilance in this region.
The key players of pharmacovigilance (PV) industry are United BioSource Corporation, Accenture, Wipro Ltd., Clinquest Group B.V., BioClinica, Cognizant, PAREXEL International Corporation, Laboratory Corporation of America Holdings, TAKE Solutions Ltd., IBM Corporation, Foresight Group International AG, ArisGlobal, and iMEDGlobal. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Medical Holography Market is one of the Key Trends Stimulating Growth of USD 4.04 billion by 2025
Mar 17, 2021: Market size and trends
The global Medical Holography Market size is projected to reach USD 4.04 billion by 2025. The market is anticipated to witness lucrative growth with a CAGR of 31.0% throughout the forecast period owing to increasing use of holography based products in biomedical research. Increasing activities and funding pertaining to R&D by key biotechnological and pharmaceutical companies is predicted to widen the scope for biomedical research activities.
Additionally, wide array of clinical applications of holography such as in dentistry, surgical & radiological procedures, cardiac electrophysiology, and orthopedics has triggered growth of the industry. Advent of technologically advanced products, such as, miniaturized light emitting diodes and pico-like projectors, which provides high clarity holographic images are predicted to accelerate demand during the forecast period.
Emerging holographic interaction and visualization technologies enabling minimally invasive procedures has led to an enhanced safety profile for patients. The abovementioned factors leading to better outcomes for patients are expected to drive physicians and patient’s preference for these products.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/medical-holography-market/request-sample
Product Insights
Holographic displays held the highest share of the product segment in 2015. The dominancy can be as a consequence of high penetration of these displays as they are an important component for viewing holograms. Moreover, the increasing modifications and advancements in holographic displays are believed to drive the demand by increasing adoption rate by physicians, researchers, and educationists.
The advancements such as incorporation of piston based displays, laser and electro-holographic is expected to be one of the high impact rendering drivers. There are several benefits associated with the above-mentioned technological advancements for diagnostic procedures, which is providing attractive growth opportunities. The benefits associated with these products include precise coordination in interventional and diagnostic applications, real-time visualization of organs and improved training.
Read Complete Report with TOC @ https://www.millioninsights.com/industry-reports/medical-holography-market
Application Insights
Owing to the benefits associated with holographic technology such as live imaging which enhanced visibility of organ is expected to boost the medical education segment and provide lucrative growth opportunities. Moreover, 3D anatomical models help in providing information and instructions in an effective manner leading to high demand and attractive growth opportunities.
In addition, this technology enables generation of full human anatomy holograms, which facilitates in revealing important disease information which is not possible with any other visualization techniques available.
End-use Insights
The largest share was held by research laboratories in 2015 owing to high adoption rate of these products for research purposes that facilitates real-time analysis of live cells & phase contrast based imaging.
Moreover, the minimally invasive nature of holographic detection thus precluding cell deformation occurring due to examination procedures and consequently rendering it as the preferred choice for researchers.
Regional Insights
A substantial share of more than 38.0% was held by North America in 2015. This can be attributed to presence of majority of key players, undertaking various research activities in the region.
High prevalence of disease in the region serves as an important growth factor leading to high clinical urgency to use medical holographs, which are becoming increasingly accessible that facilitates sophisticated imaging. Moreover, high investments in R&D are anticipated to increase holography products in research. The above-mentioned factors are expected to drive the regional market.
Asia Pacific is anticipated to witness an exponential growth during the forecast period. The growth can be attributed to rise in disposable incomes and healthcare expenditure. In addition, increasing awareness level of physicians pertaining to benefits associated with these products such as enhanced patient care & diagnosis and improved performance of physicians.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Dermatology Devices Market is Rapidly Growing Due to Growing USD 25.7 billion by 2025
Mar 17, 2021: Industry Insights
The global Dermatology Devices Market size is likely to reach USD 25.7 billion by 2025, registering at a 13.5% CAGR during the forecast period. Rising number of esthetic procedures and escalating prevalence of skin-related disorders are major factors contributing toward the growth of the market.
There has been a rise in incidences of poor skin conditions which lead to increasing number of the skin treatments performed where dermatology devices are needed. According to the International Society of Aesthetic Plastic Surgery, around 20,236 thousand aesthetic procedures were performed globally. Thus, this large number of plastic and aesthetic surgeries performed worldwide is also expected to augment the dermatology devices market. Moreover, the increasing aesthetic concern among the population has led to the increased demand for the dermatology procedures ultimately leading to the dermatology devices market growth. In addition, the hair related problems are also expected to boost the growth of the market.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/dermatology-devices-market/request-sample
Growing prevalence of skin cancer is another major factor contributing toward market growth. For instance, according to American Cancer Society, about 10,130 people die due to melanoma each year in the U.S. Thus, there is rising demand for dermatology products for the diagnosis of the skin cancer which can help the prevention of cancer at an early stage. For instance, dermatoscopes are used for the detection of skin cancer by the evaluation of pigmented lesions. Moreover, the growing technological advancements in the dermatology devices has led to the increased demand for these products. Furthermore, the increased incidence of the obese population has further led to increased demand for the liposuction procedures, where dermatology products are used, ultimately boost the market growth.
Product Insights
Based on the products, the dermatology devices market is classified into treatment and diagnostic devices. The dermatology treatment segment is estimated to dominate the market due to increasing population adopting newer dermatological or aesthetic procedures for the treatment of skin disorders and enhancement of the skin. Also, the acne-related problems are growing, which is attributed to increased demand for these products for acne treatment. This increase in the demand for the acne removal procedures has attributed to the growth of the market.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/dermatology-devices-market
The diagnostic segment is expected to grow at a significant rate over the forecast period. This is due to the increased incidence of the skin disorders and skin cancer globally, which has created an awareness among the people for early stage diagnosis of cancer.
Type Insights
There are different types of diagnostics products including dermatoscopes, imaging devices, and microscopes available for the diseases diagnosis. Among them, the imaging segment accounted for the largest revenue share in 2015 due to the increasing prevalence of skin cancer and other skin disorders. The imaging devices are widely used for the early diagnosis of the skin cancer. Based on the treatment market is classified into light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion devices, and cryotherapy devices. Amongst them, light therapy accounted for the largest market share in 2015 owing to its large usage in the acne treatment.
Liposuction devices are expected to showcase significant growth rate due to increase in the number of obese people globally and rising concern about fat removal and body contouring amongst people with obesity. Moreover, the weight management can be done by liposuction products helping in the prevention the other chronic conditions such as heart diseases and diabetes.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Biochip Market is Estimated to Showcase a Significant Growth Rate Over the Analysis Period
Mar 11, 2021: Industry Insights
Global biochips market size was valued at USD 7.63 billion in 2015. With potential applications of genomics and proteomics in biotech R&D, along with rapid technological innovation and increase in adoption of personalized medicines, it is expected that this market will witness considerable growth in revnue over the forecast period.
For biochip technology, in order to enhance its usability, there is an improvement in resolution, preparation procedures and accuracy along with the reduction in the cost of the materials associated with manufacturing the biochips. These factors are expected to further reinforce growth potential. Anticipated commercialization and launch of novel treatments and diagnosis products including non-laboratory and laboratory research is expected to fuel growth over the forecast period.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/biochip-market-size/request-sample
Current developments aiming to miniaturize biochips even further can be anticipated to increase the additional usage and applicability for genetic sequencing methodologies, such as diabetes genomics. With the rise in usage of the biochip technology, it is anticipated that cost of genome profiling can reduce even further for studies such as protein expression analysis among others. Hence, proteomics and genomics labeling techniques along with other protein profiling techniques are expected to witness a growth in demand.
Product Type Insights
DNA chips accounted for the largest share of revenue owing to the presence of a considerable number of applications. Cancer treatment/diagnostics has been observed to have major share for the usage of biochips. Other segments contributing for the applications of biochips include genotyping, agricultural biotechnology, genomic studies, single nucleotide polymorphism and gene expression.
Browse Full Report With TOC @ https://www.millioninsights.com/industry-reports/biochip-market-size
Biochip technology has the ability for miniaturizing chemical & biological assays and molecular biology which provides a ground for in-depth R&D of molecular biology at a minute level. Furthermore, the ability of miniaturization is expected to improve even more and enhance the efficiency in terms of inputs and cost requirements.
End-use Insights
Lab-on-a-chip, cell and tissue array, protein chips and DNA chips find applications in biotechnology & pharmaceutical companies, research & academic institutes, hospitals & diagnostics and point of care settings which involves end users. Protein biochips and LOACs have found widespread use for single nucleotide polymorphism genotyping, gene expression, in vitro diagnosis, expression profiling, drug discovery, high throughput screening and tissue arrays. The commercialization of the products in the development pipelines of key market participants is also key towards the potential to drive the growth for the market.
Sophisticated robotic tools are needed for scanning and handling samples which are in micro-scale. Furthermore, for efficient data analysis efficient bioinformatics system is required. Therefore, this will increase the need for specific techniques and system which is expected to increase the demand for biochips used in sophisticated machines. This will consequently increase the price of the biochips and widen the offered product range in the market.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Cosmetic Implant Market Development of Low Cost Devices to Address Growing Demand is a Major Opportunities
Mar 11, 2021: Industry Insights
The global Cosmetic Implants Market is expected to reach USD 9.29 billion by 2020 and is expected to grow at a CAGR of 6.8% over the forecast period. Rapidly changing lifestyles, increasing aesthetic awareness, and medical tourism are some of the key factors anticipated to boost the market over the forecast period. Rising healthcare expenditure, favorable government initiatives, and growing ageing population are also amongst few key factors expected to surge adoption of cosmetic implants. According to American Society of Plastic Surgeons in 2016, residents of U.S. spent nearly USD 15 billion on combined surgical and nonsurgical procedures.
Growing demand for minimally invasive surgeries and increasing cosmetic surgeries drive the growth of this market. According to the data published by the American Society of Plastic Surgeons in 2015, the minimally invasive cosmetic surgeries performed were 15.9 million demonstrating 2% increase since 2014 in the U.S. Technological advancements in the field of cosmetic implant surgeries including tissue engineering, microsurgery procedures, and computer assisted process offers advantages of minimal or no visible scars and thereby further drive the demand for the implants.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/cosmetic-implant-market/request-sample
Rising incidences of breast cancer escalate number of women undertaking the breast reconstruction and augmentation procedures, which is anticipated to boost demand for breast implants such as silicon and saline filled breast implants. Some of the key factors such as growing awareness towards aesthetic appearance and anti-ageing treatment also propel the market growth. According to the International Society of Aesthetic Plastic Surgery, globally there were about 21,696,671aesthetic procedures performed in 2015.
Application Insights
On the basis of applications, the market is segmented as dental, breast, facial, penile, and calf implants. Dental implants held the largest market share of about USD 3.45 billion in 2016. Factors such as increasing dental injuries and growing advancements in technologies including mini implants, CAD/CAM technology, and nanostructured titanium implants is expected to boost the market. Rising concerns for oral healthcare and increase in geriatric population also drive the growth of the market. According to American Association of Oral and Maxillofacial Surgeons survey conducted in the U.S, about 30 million people have lost teeth in one or both jaws and more than 15 million people are with the bridges or crowns.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/cosmetic-implant-market
Facial implants segment is anticipated to be the fastest growing segment with a CAGR of 10.3%. Some of the key factors such as rising demand for minimally invasive surgeries and increasing incidence of facial and sports related trauma drive the demand for facial implants in the market. However, rising incidences of breast cancer and growing number of breast augmentation and reconstruction surgeries is further anticipated to boost up the demand for breast implants. According to The American Society of Plastic Surgeons (ASPS), breast augmentation is among the top five cosmetic procedures in U.S. About 279,143 number of breast augmentation procedures were conducted in the U.S.
Raw Material Insights
Based on the raw materials, the market is segmented into polymers, ceramics, metals, and biological materials. Polymer based implants accounted for largest market share owing to its properties of high durability, flexibility, and ease in availability. Polymer implants can be easily mold into various shapes that can be used for manufacturing of different cosmetic implants like facial, breast, and body contouring implants.
Ceramic implant market is expected to grow with its increasing usage in dental implants as it has high resemblance with the natural tooth and is more aesthetically appealing. Metal implants including stainless steel, pure titanium, and cobalt-chromium are used in the cosmetic and reconstructive surgery for over 35 years. However, growing concerns regarding its safety and efficacy may hamper the market growth. Biological materials are expected to grow at significant rate with a CAGR of about 10.9% owing to rising awareness of the benefits it provide to the consumer.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Disposable Lead Wires Market is Expected to Increase Over the Forecast Period of 2025
Mar 11, 2021: Industry Insights
The global disposable lead wires market size was worth USD 545.0 million in 2015 and is anticipated to grow at CAGR of 6.3% in coming years. Escalating incidence of cardiovascular diseases resulted into growing adoption of ECG equipment and accessories thereby fueling the demand for ECG lead wires (LWs) during the forecast period. Reusable LWs can cause blood stream infections since these LWs are the prime source for proliferating antibiotic resistant bacteria in patients which resulted in shifting of preference toward disposable LWs over the forecast period.
In addition, growing geriatric population base is anticipated to broaden the consumer base as old age people are at higher risk for cardiovascular disorders, which is anticipated to trigger the demand for patient monitoring devices, which consists of disposable LWs in coming years.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/disposable-lead-wires-market/request-sample
Furthermore, escalating healthcare associated infections is a major contributing factor expected to drive the market growth. As per the study published in the white paper of SunTech Medical Inc., each year 2 million people acquired healthcare associated infections in the U.S. alone and the incidence is expected to grow over the forecast period. The previously mentioned elements are crediting toward the growth in coming years.
Material Insights
In 2015, Thermoplastic Elastomer (TPE) held the dominant share of the material segment. The substantial share is attributing to the associated advantages with its usage including compatibility, high cost efficiency, high insulation properties and stability. The segment is further expected to enlist exponential development during the forecast period as a result of rising adoption and applicability in various applications.
Thermoplastic polyurethanes (TPUs) are a type of TPEs and are long-chain linear polymers having no cross-links. The TPU material provides abrasion resistance, biocompatibility, biostability and low-temperature elasticity, which makes them the best material for manufacturing of LWs. The TPU-based LWs are usually resistant to abrasion, exhibit acid-base resistance, fungus and heat. The previously mentioned benefits with the utilization of TPUs are anticipated to boost the usage rates over the forecast period.
Read Complete Report with TOC @ https://www.millioninsights.com/industry-reports/disposable-lead-wires-market
Machine Insights
Other segments which include 6, 12, 15 and 18 lead of machine type accounted for the substantial share in 2015. This is creditable to persistent adoption as a result of larger preference owing to the related advantages such as ease of use, efficiency and flexibility.
In addition, 5-lead machine type is anticipated to grow at a lucrative growth rate over the forecast period. This is ventured to be an outcome of persistent usage in cardiology and patient monitoring systems in coming years.
End-Use Insights
Hospital segment held a leading position in the market of disposable LWs in 2015. This can be ascribed to their extensive machine varieties of disposable LWs in hospitals. Due to associated advantages with the utilization of disposable LWs and rising prevalence of hospital acquired infections the usage of disposable LWs in hospitals is anticipated to demonstrate an upward shift in near future.
While clinics are expected to show lucrative growth owing to rising demand for remote patient monitoring services and increasing awareness amongst end-users. The benefit of clinics is that they offer physicians’ quick access to the results, speeding the diagnostic process; subsequently, the demand for LWs in the clinical settings is huge due to the necessary requirement to keep up a hygienic and non- contaminated environment.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Atrial Fibrillation Market is Expected to be the Fastest-Growth During the Forecast Period
Mar 08, 2021: Market Snapshot:
The scope of the global Atrial Fibrillation Market is projected to touch US$ 16.17 billion by 2020, growing at a CAGR of 13.2% for the duration of the forecast. This could be attributed to increase in incidences of atrial fibrillation amongst geriatric population, rise in preference for catheter ablation to treat cardiac arrhythmia, and technological advancements.
Atrial fibrillation comes across as an irregular or a rapid rhythm pertaining to the heart that, in turn, does increase risk of stroke, cardiovascular diseases, and several other complications like chest pain, discomfort (Angina). The symptoms include dizziness, fainting, fatigue, and confusion.
Market Segmentation:
The atrial fibrillation market is segmented based on device and geography. By device, it spans surgical devices and non-surgical devices. Surgical devices could be sub-segmented into maze surgery, catheter ablation (radiofrequency catheter ablation (conventional RF ablation catheters and irrigated-tip RF ablation catheters)), cryoablation, microwave based catheter ablation, laser based catheter ablation, and navigational advanced mapping accessories.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/atrial-fibrillation-market/request-sample
The “non-surgical” devices are sub-segmented into electric cardioversion, diagnostic catheters (conventional diagnostic catheters (fixed diagnostic catheters, steerable diagnostic catheters), advanced diagnostic catheters), mapping and recording systems, cardiac monitors, access devices, left atrial appendage and closure devices, and Intracardiac Echocardiography (ICE) systems.
Regional Insights:
By geography, the atrial fibrillation industry says North America, Europe, Asia Pacific, and LAMEA. North America holds the largest market share due to prevalence of refined healthcare infrastructure in the U.S. and Canada. Europe comes in second due to Denmark and Belgium being the healthcare capitals. Asia Pacific is expected to grow at the fastest rate due to sedentary lifestyle calling for loads of cardiac diseases. Besides, economies like China and India are asking for AF devices; which are likely to put Asia Pacific on the top in the near future.
Browse Complete Summary Click Here @ https://www.millioninsights.com/industry-reports/atrial-fibrillation-market
Market Insights:
Extensive instance – in 2016, Boehringer Ingelheim Pharmaceuticals, Inc., in partnership with Heart Rhythm Society, did award “Atrial Fibrillation (AFib) Quality Improvement (QI) Innovation Grant” to Dr. Steven A. Lubitz (MD, MPH, Massachusetts General Hospital) and Dr. Mark H. Eckman (MD, University of Cincinnati) for encouraging research on preventing atrial fibrillation and stroke.research is being carried out with regards to Atrial fibrillation. Novel treatments like FIRM ablation, Watchman device, and Convergent procedure are seeing success in around 75-80% of patients. Players are also engaging in organic mode of development. For
Players:
The other players contributing to the atrial fibrillation market include CardioFocus, Inc., Osypka AG, Japan Lifeline Co., EndoPhotonix, Inc., CathRx Ltd., Biosense Webster, Inc., TZ Medical, GE Healthcare, and Pioneer Medical Devices AG.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes
Text
Biosimilars Market is Experiencing Significant Growth Due to the Rising US$ 61.47 billion by 2025
Mar 08, 2021: Synopsis:
The scope of the global Biosimilars Market was appreciated by US$ 4.36 billion in 2016. It is projected to touch US$ 61.47 billion by the completion of 2025. It is likely to increase at a CAGR of 34.2% during the period of forecast. Most important biological medicines are upcoming the patent precipice. This is the greatest noteworthy motivating feature for the market. For example, Roche’s Mab Thera/Rituxan (rituximab), a monoclonal antibody biologic was accepted by the U.S. Food &Drug Administration (FDA) during November 1997 and its patent taken in the U.S.A, terminated in September 2016. A number of companies for example Pfizer, Amgen and Boehringer Ingelheim are concentrating on the development of biosimilars medication of rituximab.
Biosimilars are extremely matching to accepted biologic medicines. They have alike medicinal possessions by means of the effectiveness, safety, and the potency to original biologic goods. Greater occurrence of long-lasting illnesses for example anemia, cancer, lack of development hormone and diabetes, is likely to additionally power the growth of the market during the upcoming period.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/biosimilars-market/request-sample
Drivers:
The price efficiency of biosimilars medicines and greater occurrence of long-lasting complaints all over the world, are round about the most important reasons funding to the development of the market.
Entire prices of healthcare have augmented owing to the greater costs of patented medicinal preparations, particularly biologics. The administrations of numerous nation state are stressing on creation of price operative medication. The U.S.A. is well-known as the nation having the maximum health expenses. It has newly put stress on decreasing the expenses on healthcare. In the same way, price guideline in Japan and abridged budget of healthcare in India, have elevated the demands for price repression. This fetches the necessity for developing reasonably priced, better-quality, effective and new-fangled treatments. Hence, hard work to bring down healthcare payments is expected to increase the biosimilar market.
Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/biosimilars-market
Restraints:
Strict rules by the government for the development and manufacture of biosimilars could hamper the development of the biosimilars industry. Precise strategies are delivered by numerous governing establishments to uphold care profile and efficiency of planned medications. Dissimilar controlling organizations comprising China Food & Drug Administration, European Medicines Agency, U.S. Food & Drug Administration (FDA), have varied guidelines for endorsements of the medication. Existence of diverse guidelines make endorsement procedure of biosimilar medicine extremely time consuming and tiresome.
Classification:
The global biosimilars market can be classified by Application, Product, and Region. By Application, it can be classified as Growth Hormonal Deficit, Oncology, Chronic and Autoimmune Complaints, Blood Disorders, and others. By Product, it can be classified as Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins.
Regional Lookout:
By Region the global biosimilar industry can be classified as North America, Europe, Asia Pacific, and Rest of the World (RoW). Due to the existence of definite controlling background for biosimilars and the most important biopharmaceutical companies for example GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, Sanofi, Pfizer, and Novartis, Europe has retained the biggest share of the market by means of an income. Additionally, finely honed structure of healthcare and increasing number of product presentations have powered the development of the local market.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
0 notes